Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003769 · ClinicalTrials.gov registry record · Phase 2
Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer
A Phase 2 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00003769: Completed Phase 2 study, sponsored by Indiana University.
NCT00003769 is a Phase 2 study that has completed, run by Indiana University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003769, a Phase 2 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Phase II trial to study the effectiveness of perillyl alcohol followed by surgery in treating patients who have stage II or stage III pancreatic cancer.
Interventions
- DRUG perillyl alcohol
- PROCEDURE surgical procedure
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-02 |
| Est. Completion | 2001-07 |
| Phase | Phase 2 |
What the finished NCT00003769 record still lists
NCT00003769 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which perillyl alcohol is the first listed.
NCT00003769 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003769 about?
NCT00003769 is a clinical study titled "Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Phase II trial to study the effectiveness of perillyl alcohol followed b...
What is the current status of trial NCT00003769?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-02. Estimated completion is 2001-07.
What interventions are being tested in trial NCT00003769?
The interventions under investigation include: perillyl alcohol (DRUG), surgical procedure (PROCEDURE).
Who is sponsoring clinical trial NCT00003769?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia